Variation in prenatal surveillance and management of anti-SSA/Ro autoantibody positive pregnancies

References

• Izmirly PM, Saxena A, Kim MY, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation. 2011;124(18):1–7. doi: 10.1161/CIRCULATIONAHA.111.033894.
   Web of Science ®Google Scholar
• Jaeggi E, Kulasingam V, Chen J, et al. Maternal anti-Ro antibody titers obtained with commercially available immunoassays are strongly associated with immune-mediated fetal heart disease. Arthritis Rheumatol. 2023;75(9):1556–1565. doi: 10.1002/art.42513.
   PubMed Web of Science ®Google Scholar
• Kaizer AM, Lindblade C, Clancy R, et al. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers. Am J Obstet Gynecol. 2022;227(5):761.e1. doi: 10.1016/j.ajog.2022.05.071.
   PubMed Web of Science ®Google Scholar
• Reed JH, Clancy RM, Lee KH, et al. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus. Arthritis Care Res (Hoboken). 2012;64(9):1373–1381. doi: 10.1002/acr.21704.
   PubMed Web of Science ®Google Scholar
• Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183–2242. doi: 10.1161/01.cir.0000437597.44550.5d.
   PubMed Web of Science ®Google Scholar
• Cuneo BF, Moon-Grady AJ, Sonesson SE, et al. Heart sounds at home: feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies. J Perinatol. 2017;37(3):226–230. doi: 10.1038/jp.2016.220.
   PubMed Web of Science ®Google Scholar
• Cuneo BF, Sonesson SE, Levasseur S, et al. Home monitoring for fetal heart rhythm during anti-Ro pregnancies. J Am Coll Cardiol. 2018;72(16):1940–1951. doi: 10.1016/j.jacc.2018.07.076.
   PubMed Web of Science ®Google Scholar
• Kaplinski M, Cuneo BF. Novel approaches to the surveillance and management of fetuses at risk for anti-Ro/SSA mediated atrioventricular block. Semin Perinatol. 2022;46(4):151585. doi: 10.1016/j.semperi.2022.151585.
   PubMed Web of Science ®Google Scholar
• Jaeggi E, Laskin C, Hamilton R, et al. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010;55(24):2778–2784. doi: 10.1016/j.jacc.2010.02.042.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Masson M, Izmirly CG, et al. Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA/Ro pregnancies. Arthritis Rheumatol. 2024;76(3):411–420.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Eudy AM, Kiernan E, et al. The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. Rheumatology (Oxford). 2018;57(suppl_5):v9–v17. doi: 10.1093/rheumatology/key141.
   PubMedGoogle Scholar
• Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
   PubMed Web of Science ®Google Scholar
• For Maternal-Fetal Medicine. Electronic Address Pso S, Silver R, Craigo S, et al. Society for Maternal-Fetal Medicine Consult Series #64: systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 2023;228(3):B41–B60.
   PubMed Web of Science ®Google Scholar
• Cuneo BF, Buyon JP, Sammaritano L, et al. Knowledge is power: regarding SMFM consult series #64: systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 2023;229(4):361–363. doi: 10.1016/j.ajog.2023.06.040.
   PubMed Web of Science ®Google Scholar
• Osmundson SS, Grobman W, Silver R, et al. Society for maternal-fetal medicine response to Cuneo et al. Am J Obstet Gynecol. 2023;229(4):364–365. doi: 10.1016/j.ajog.2023.06.039.
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11(5):301–312. doi: 10.1038/nrrheum.2015.29.
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Capecchi PL, Laghi-Pasini F. Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications. Heart Rhythm. 2015;12(2):449–454. doi: 10.1016/j.hrthm.2014.10.031.
   PubMed Web of Science ®Google Scholar